OncoCyte (OCX)
(Real Time Quote from BATS)
$3.24 USD
+0.07 (2.21%)
Updated Jul 23, 2024 03:43 PM ET
After-Market: $3.22 -0.02 (-0.62%) 4:18 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Top 39% (98 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.40 | 1.51 | 9.99 |
Current Quarter Estimate | NA | 1.48 | 61.00 |
Year Ago Quarter Estimate | -1.07 | 0.51 | 54.84 |
Next Quarter Estimate | NA | 1.51 | 63.00 |
Next Year Estimate | NA | 8.09 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 40.96 | 13.10 | 15.67 |
Next Year | NA | 21.00 | 9.31 |
Last 5 Years | NA | 9.50 | 8.10 |
Next 5 Years | NA | 14.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 17.34 |
Price/Book (MRQ) | 2.26 | 2.05 |
Price/Cash Flow (MRFY) | NA | 12.42 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -2,905.14% | 5.80% |
Return on Equity (TTM) | -135.45% | 8.16% |
Debt to Equity (MRQ) | NA | 33.68 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.